15-31001792-T-TA
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BS1_Supporting
The ENST00000256552.11(TRPM1):c.*29_*30insT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00977 in 1,129,630 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00034 ( 0 hom., cov: 32)
Exomes 𝑓: 0.011 ( 0 hom. )
Consequence
TRPM1
ENST00000256552.11 3_prime_UTR
ENST00000256552.11 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -1.44
Genes affected
TRPM1 (HGNC:7146): (transient receptor potential cation channel subfamily M member 1) This gene encodes a member of the transient receptor potential melastatin subfamily of transient receptor potential ion channels. The encoded protein is a calcium permeable cation channel that is expressed in melanocytes and may play a role in melanin synthesis. Specific mutations in this gene are the cause autosomal recessive complete congenital stationary night blindness-1C. The expression of this protein is inversely correlated with melanoma aggressiveness and as such it is used as a prognostic marker for melanoma metastasis. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Oct 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BS1
Variant frequency is greater than expected in population nfe. gnomad4_exome allele frequency = 0.0112 (10985/980424) while in subpopulation NFE AF= 0.0119 (8878/745492). AF 95% confidence interval is 0.0117. There are 0 homozygotes in gnomad4_exome. There are 5195 alleles in male gnomad4_exome subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRPM1 | NM_001252024.2 | c.*29_*30insT | 3_prime_UTR_variant | 28/28 | ENST00000256552.11 | NP_001238953.1 | ||
TRPM1 | NM_001252020.2 | c.*29_*30insT | 3_prime_UTR_variant | 27/27 | NP_001238949.1 | |||
TRPM1 | NM_002420.6 | c.*29_*30insT | 3_prime_UTR_variant | 27/27 | NP_002411.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRPM1 | ENST00000256552.11 | c.*29_*30insT | 3_prime_UTR_variant | 28/28 | 1 | NM_001252024.2 | ENSP00000256552 | P4 | ||
ENST00000665655.1 | n.71+9562dup | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000335 AC: 50AN: 149130Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
50
AN:
149130
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0112 AC: 10985AN: 980424Hom.: 0 Cov.: 32 AF XY: 0.0106 AC XY: 5195AN XY: 487944
GnomAD4 exome
AF:
AC:
10985
AN:
980424
Hom.:
Cov.:
32
AF XY:
AC XY:
5195
AN XY:
487944
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000335 AC: 50AN: 149206Hom.: 0 Cov.: 32 AF XY: 0.000412 AC XY: 30AN XY: 72732
GnomAD4 genome
AF:
AC:
50
AN:
149206
Hom.:
Cov.:
32
AF XY:
AC XY:
30
AN XY:
72732
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Congenital Stationary Night Blindness, Recessive Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at